John A Kalapurakal

  • 2192 Citations
19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Primary research interests are in adult and pediatric genito-urinary and CNS cancers including prostate cancer, Wilms tumor and brain tumors. The other areas of interest include development of novel therapies for recurrent tumors including prostate, brain, sarcomas, Wilms tumor and neuroblastoma. Radiosurgery, hyperthermia,intra-operative radiation therapy, brachytherapy, novel IMRT techniques, proton therapy and nanoparticle-mediated delivery of novel radiosensitizing therapy are areas of ongoing clinical and basic research.

Certifications and Licenses

Radiation Oncology

Training Experience

1993Residency, Erlanger Medical Center
1997Residency, Temple University Hospital

Education/Academic qualification

MD, Medical College Kottayam, India

… → 1988

Research interests

  • Brain Cancer / Nervous System Cancer
  • Kidney Cancer / Urinary Tract Cancer
  • Pediatrics
  • Prostate Cancer
  • Radiation Oncology
  • Urology

Fingerprint Dive into the research topics where John A Kalapurakal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

  • Research Output

    Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group

    Ehrlich, P. F., Chi, Y. Y., Chintagumpala, M. M., Hoffer, F. A., Perlman, E. J., Kalapurakal, J. A., Tornwall, B., Warwick, A., Shamberger, R. C., Khanna, G., Hamilton, T. E., Gow, K. W., Paulino, A. C., Gratias, E. J., Mullen, E. A., Geller, J. I., Grundy, P. E., Fernandez, C. V. & Dome, J. S., Aug 1 2020, In : Cancer. 126, 15, p. 3516-3525 10 p.

    Research output: Contribution to journalArticle

  • Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor: A Children's Oncology Group AREN0532 and AREN0533 study report

    behalf of the AREN0532 and AREN0533 study committees., 2019, In : Journal of Clinical Oncology. 37, 30, p. 2769-2777 9 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial

    Kalapurakal, J. A., Gopalakrishnan, M., Walterhouse, D. O., Rigsby, C. K., Rademaker, A. W., Helenowski, I., Kessel, S., Morano, K., Laurie, F., Ulin, K., Esiashvili, N., Katzenstein, H., Marcus, K., Followill, D. S., Wolden, S. L., Mahajan, A. & Fitzgerald, T. J., Jan 1 2019, In : International Journal of Radiation Oncology Biology Physics. 103, 1, p. 28-37 10 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations